Manipulation of protein stability using small molecules has a great potential for both basic research and clinical therapy. Based on our protein knockdown technology, we developed chimeric degrader molecules SNIPER(ER)s that target the estrogen receptor alpha (ERα) for degradation via the ubiquitin-proteasome system. This chapter describes the design and synthesis of SNIPER(ER) compounds and methods for the evaluation of their activity in cellular systems and in a tumor xenograft model.
Keywords: Antitumor activity; Cell death; Estrogen receptor; Protein knockdown; SNIPER; Ubiquitin-proteasome system.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.